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Abstract
Due to the poor regenerative potential of adult heart tissue, heart disease is a major cause 
of death worldwide. With developments in cell biology, researchers have gravitated towards 
investigating the applications of stem cells to aid in cardiac regeneration through injection of 
cardiac progenitors into the site of infarction. This method has led to promising results in 
mammalian studies but to bolster current cardiac research, research tools are required to observe 
the physiology and quantify the success of differentiation in ES derived cardiac cells. I have 
attempted to create one such research tool by creating a visual and quantifiable detection method 
for the differentiation of human iPS cells into beating cardiomyocytes through my creation of an 
aMHC-GCaMP8 insertion plasmid. Transforming this plasmid into iPSCs will allow GCaMP8 
to fluorescently monitor Calcium levels in differentiated cardiomyocytes, taking advantage of the 
physiological Calcium fluctuations associated with muscle contractions. Though I was unable to 
confirm creation of this plasmid due to time constraints and unexpected errors, my work can still 
be finished or expanded upon transforming cells with my plasmid and creating cells with 
countless applications both in differentiation analysis, disease modeling, and tissue engineering.
Introduction
In an examination of historical art and literature, the heart has been a symbol for love, 
emotions, and even the soul. As modern science has evolved and humans have learned more 
about anatomical function, these ideas have been generally abandoned with the heart instead 
becoming associated with an early death. In the 20th century heart disease surpassed infectious 
disease as the leading cause of death worldwide and in 2009 1 in 9 death certificates in the 
United States mentioned heart failure [12], Developed from the mesoderm, the heart is an organ
that facilitates the pumping of blood throughout the body. Proper heart function is an integral 
factor in advanced organism life due to its role in delivering nutrients and helping remove waste. 
In this honors thesis, I attempt to create a research tool for studying heart cells and with future 
utilization of advances in stem cell studies, gene engineering, and calcium labeling tools; this 
tool can realize its potential and help study heart disease.
While heart disease stands as an unsolved problem within the medical community, 
current research has implemented new methods of heart repair particularly through the use of 
stem cells. Embryonic stem (ES) cells are undifferentiated cells derived from the inner cell mass 
of a blastocyst and have the potential to give rise to any cell or tissue type within the human 
body. This pluripotency has led researchers to attempt to create human organs from scratch and 
inject specific cells into damaged tissue to aid in repair. Due to the extremely low regenerative 
potential of adult cardiac cells, injection of ES derived cardiac cells into areas of damage is 
considered a very promising method of heart cell regeneration [11, 14], This has been confirmed 
experimentally for mouse models post myocardial infarction using both ES cells and 
hematopoietic bone marrow cells, and in primate models where human ES derived 
cardiomyocytes aided in regeneration [10, 23, 24], These exciting methods of tissue repair hit a 
speedbump for clinical human therapy due to the ethical and social implications behind the 
gathering of ES cells from a fertilized human embryo, and the negative immune response to 
injection of foreign cells into a host.
To circumvent these issues researchers looked for new ways to create endogenous human 
pluripotent embryonic stem cells without the destruction of embryonic material. Through an 
understanding of gene expression and frog studies from the 1950s and 60s, researchers found 
that transfer of a mammalian oocyte nucleus into a terminally differentiated cell caused
reprogramming of the cell into an undifferentiated state suggesting that every differentiated cell 
has the potential to be reprogrammed based on different gene expression. Further examination of 
genes with high expression in human ES cells led to the discovery of specific factors (in 
particular OCT4, SOX2, NANOG, and LIN28) are responsible for the pluripotent phenotype and 
thus, induced pluripotent stem cells (iPSC) were discovered [36], These cells are taken from 
differentiated adult tissue and after activation of specific master transcription factors, are 
undifferentiated to pluripotency. This exciting new development does have its limitations, 
though, as the method of iPSC creation and differentiation is not completely perfected. The use 
of iPSC to aid in regeneration therapies is a dream for modern cell biologists and if perfected 
will add a personalized and specific new angle to aid in heart repair [11, 26],
The second major biological advance that I utilize in my project is gene editing nucleases 
that can be engineered to target specific genes and sites. With the advent of iPS cell creation, 
researchers have become particularly interested in editing and targeting specific genes in 
attempts to create patient derived cells modeling genetic diseases [4], These cells can then be 
used for further testing, exploring novel drugs treatments and the basic biology of genetic 
disorders [28], This methodology doesn’t come without limitations, though, as transfection of 
iPSCs is a difficult procedure because they grow poorly as single cells (a practice required for 
selection of rare targeted clones) and off target DNA insertion may alter differentiation potential 
or introduce malignant mutations [9, 12], To avoid the potential confounding off target effects, 
scientists have developed site specific editing machinery, the most popular being zinc-finger 
(ZF) domains, CRISPR-Cas9 machinery, and transcription activator-like effector nucleases 
(TALEN) with TALENs being of particular interest in my project [14], These editing methods 
localize to a particular sequence of interest and induce cuts at that sequence with nucleases
thereby causing mutations or insertions through error prone non-homologous end joining 
(NHEJ), or homology directed repair (HDR) pathways. These methods have allowed scientists to 
create more effective means of transfecting cells into ‘safe harbor’ locations where a specific 
segment such that a gene of interest is inserted through homologous recombination during the 
HDR pathway [6, 13],
A third biological advance is the utilization of optogenetic markers to monitor expression 
of specific genes and intracellular ions, particularly calcium. Our current understanding started 
with the discovery and isolation of green fluorescent protein(GFP) from the jellyfish Aequorea 
victoria [8], GFP fluoresces green light under specific wavelengths, has no known unwanted 
phenotypic effects, and allows researchers to test for expression of specific genes when that gene 
is coupled to GFP. Utilizing GFP, GCaMP, a genetically encoded calcium indicator (GECI), was 
created through the fusion of GFP, calmodulin and Ml 3 (a sequence from myosin light chain 
kinase) [21], With a further research to create mutations in GCaMP, multiple different indicators 
have been created varying in sensitivity and response [22, 37], The research potential of these 
calcium monitoring genes is immense particularly in neurological and cardiac studies due to the 
major physiological role calcium plays in neuron firing and muscle contractions [3, 17, 31],
Utilizing an understanding of iPS cells, genome editing, and optogenetic markers, I 
hypothesized that it is possible to create a line of iPSCs that, when differentiated into beating 
cardiomyocytes, would glow with varying calcium levels associated with the beating. This is the 
crux of my project and though I only had time to complete some cellular and molecular biology 
experiments, I have outlined methods to complete this larger gene insertion process. The 
methodology can be split into distinct parts; creation of insertion plasmid, transfection and 
transformation of iPSCs, selection for cells with proper gene insertion, differentiation of cells
into cardiomyocytes, and recording fluorescent output associated with beating. To create the 
plasmid, I needed to have a selection component, insertion machinery, and labeling mechanism. 
Fortunately, the Kotlikofflab specializes in optogenetics and I had access to a plasmid with a 
GCaMP8 coupled to an aMHC resulting in GCaMP8 expression when the cells are differentiated 
into heart cells due to aMHC being a known marker of cardiac cells providing the labeling 
mechanism [19], I then found a study where there was insertion of a plasmid and selection into 
iPSCs through TALEN transfection and transformation, providing an insertion and selection 
method [6], These plasmids were subject to restriction digests creating blunt and sticky ends and 
then were ligated maintaining the TALEN arms, the neomycin gene, and the aMHC-GCaMP8 
cassette (figure 14). The arms will allow specific homologous recombination to occur inserting 
the neomycin for antibiotic selection and an aMHC-GCaMP8.
With the creation of this plasmid, TALEN transfection and selection protocols similar to 
Cerbini et al and differentiation protocols used by the Conklin lab, Burridge, and Van Berg [6, 5, 
33] should be performed. Utilizing protocols outlined by Cerbini et al, the insertion of this 
plasmid with be facilitated through electroporation followed by TALEN cutting and insertion of 
the plasmid into the CLYBL ‘safe harbor’ locus that is constitively expressed in human cells [6, 
16] (figure 2b). The cells will then be subject to antibiotic treatment and differentiated using 
varying protocols. If all the prior steps are successful, the cells will fluoresce upon beating due to 
the active aMHC-GCaMP8.
While the methods outlined above were largely incomplete, I successfully isolated an 
aMHC-GCaMP8 insert, CAG vector, ligated and transformed bacterial cells (with successful 
plasmid creation still to be determined), created an antibiotic kill curve for my cells, and proved 
pluripotency and successful cardiac differentiation of my cells through observational and gene
expression analysis. Though the line of engineered cells was not created, the protocols and ideas 
I use pave the way for new research tools that could change the way we study calcium 
fluctuations in human cells, particularly cardiac cells.
Methods
The major methods utilized throughout my research is characterized by creation of an 
insertion plasmid, transfection of iPSCs with said plasmid, selection of cells for proper plasmid 
insertion, differentiation of cells, and measuring fluorescent output associated with beating. The 
Kotlikoff lab specializes in creating transgenic mice for different types of cellular imaging so the 
creation of the insertion plasmid protocol is original created by my colleagues and I through our 
understanding of molecular biology. The other aspects of the project were based on protocols 
used by Cerbini et al., particularly when it came to the transfection and colony selection of the 
engineered iPS cells [6, 7], Furthermore, many differentiation protocols were attempted and 
based on protocols from the Conklin lab (through correspondence), Burridge et al, and Van Berg 
et al [5, 32],
Creation of insertion plasmid
1. Preparation of pC13N-iCAG.copGFP (CAG) (Addgene 66578) through removal of CAG- 
GFP cassette creating a linear vector with a sticky end and a blunt end while retaining 
homologous TALEN arms and neomycin gene (see Figure 1);
a) Plasmid was acquired in agar stock. Was grown in overnight in kanamycin and isolated 
using GeneJET Plasmid Miniprep Kit (Thermo Scientific #K0502) according to the 
manufacturer’s protocol.
b) Digest with ASCI (unique cut at 5389):
50 ul plasmid DNA
5 ul NEB cutsmart buffer (NEB)
2 ul ASCI (NEB)
33 ul H20
total volume = 50ul. Digested at 37°C for 1-2 hour, resulting in a linear fragment of 
10973bp with -GCGC 5’ overhangs.
c) Fill in 5’ overhang with Klenow fragment to create blunt end.
50 ul ASCI digested plasmid
1 ul Klenow fragment (Fermentas EP0051)
Incubate at 37°C for 10 minutes.
d) Gel purify blunt ended AscI digested plasmid:
1% agarose gel (long) with a wide lane was prepared using SybrSafe as a gel stain in the 
gel. All 50ul of product was run on the gel, along with a lkb ladder plus marker.
The gel was imaged, minimizing the exposure to the UV light to avoid DNA damage. On 
a UV gel box, the band of interest (singular at 10973 base pairs long) was cut out using a
razor blade and put into a 1.5 ml Eppendorf tube (pre-weighed). The mass of my band of 
DNA was determined and purified from the gel following the instructions for the GeneJet 
gel purification protocol (Thermo Scientific GeneJET Gel Extraction Kit #K0691). I 
eluted the DNA in 30 ul of elution buffer and ran ~3 ul of the eluted DNA was then run 
on a 1% gel to check purity and concentration.
) I digested the gel purified, blunt ended ASCI fragment with with EcoRI to create a sticky 
end and excise the CAG-GFP cassette (cuts at 5396 and 7954).
50ul DNA from step (c)
5 ul cutsmart buffer 
3 ul EcoRI enzyme 
0.5 ul H20
total volume = 30 ul. Digest at 37°C for 1 hour.
This digest should result in 2 fragments, 2559bp and 8414bp. The 2559 fragment is the 
CAG-GFP fragment that I wanted to remove. The 8414bp fragment was isolated using 
the GeneJet gel extraction kit similar to step lc. This fragment will have one EcoRI end 
and one blunt end. 3ul was ran to check purity and concentration. The CAG vector is 
now ready to use.
2. Purification of aMHC-GCaMP8 insert with a sticky end and a blunt end for insertion into the 
CAG vector (figure 2a).
a) Digest aMHC -GCaMP8 plasmid (acquired from Kotlikofflab) with HindTTT resulting in 
a 10-1 lkb linear fragment, while simultaneously dephosphorylating the 5’ends.
5 uL DNA
5 ul lOx fast digest buffer 
5 ul Hindlll (NEB)
5 ul FastAP alkaline phosphatase (NEB)
30ul water
total volume = 50 ul. Digest at 37oC for 10 minutes.
b) Plasmid was gel purified as described in lc.
c) A Mfel linker (eurofins MWG Operon) was prepared through;
i) resuspension in 10mM Tris, pH 7.5-8.0, 50mM NaCl, ImM EDTA to a lOOuM 
concentration.
ii) Heat to 94°C for 3-5 minutes
iii) Remove the heat block from the heater and allow to slowly cool to room temperature 
(will take 45-60 minutes).
iv) Store at 4°C until ready to use.
d. Ligate the Mfel linker to the HindlEI digested aMHC-GCaMP8 plasmid replacing the
Hindlll site with an Mfel site.
3 ul of Hind III digested aMHC-GCaMP8 
3 ul of Mfel linker 
1 ul ligase buffer 
1 ul T4 DNA ligase 
1 ul H20
incubated at room temperature overnight. Note: a control ligation was also run where no 
mfel linker was added. Ligation will occur at this site 
5’ AGC TC TGCAATTGCAG 3’
3’ GACGTTAACGTCTCGA 5’
e. Transform DH5a competent cells (Invitrogen #18-265-017) with plasmid from ligation 
reaction according to manufacturer’s protocol. Plated on ampicillin plates and grown 
overnight.
f. I then picked 10 colonies, grow them overnight in LB-amp stock and performed 
minipreps to isolate the ligated plasmid.
g. The 10 colonies were tested for proper Mfel ligation through trial HindTTT and Mfel 
digests along with sequencing analysis for the linker.
h. Digest the Mfel containing plasmid with Notl resulting in a 2 linear fragments of 2,887bp 
and 7,517bp.
5ul plasmid DNA 
2 ul NEBuffer 3.1 (NEB)
1 ul Notl 
12 ul H20
total volume = 20ul. Digest at 37°C for 1-2 hour.
i. Fill in 5’ overhang with Klenow fragment creating blunt end at Notl digest site:
20 ul Notl digested plasmid
0.5 ul Klenow fragment (Fermentas EP0051)
incubate at 37°C for 10 minutes. Heat inactivate at 75°C for 10 minutes.
j . Gel purify blunt ended Notl digested plasmid at 7,517 bp as described in lc.
k. Mfel digest linear purified product creating sticky Mfel site.
25 ul plasmid DNA
4 ul cutsmart
2 ul Mfel 
9 ul water
Total volume= 40 ul. Digested at 37oC for 1-2 hour.
1. Gel purify Notl/Mfel digested DNA, isolating the 6,816 bp band.
3. Ligate the Fragments and isolate the TALEN GCaMP8 plasmid.
a) Ligate 6000bp aMHC-GCAMP8 fragment with CAG fragment at a 1:3 insert to vector 
ratio overnight, (concentrations determined through nanodropper readings and 
stoichiometry)
9 ul aMHC-GCaMP8 
3 ul CAG vector 
2 ul ligase buffer 
1 ul T4 DNA ligase 
5 ul H20
Note: A control should be prepared using CAG vector from step lb without insert
b) Transform DH5a competent cells and plate on kanamycin selecting for bacteria with 
correctly ligated plasmids inserted using the same protocol as in 2e. Note: an additional 
control used should be an undigested plasmid from step la or 2a.
c) Identify clones that are positive, perform miniprep to isolate DNA, and sequence to 
confirm accuracy of insertion plasmid creation (figure 14).
Transfection of hiPS Cells
The transfection protocol that I would’ve used is nearly identical to that used by Cerbini
et al. 3*10A6 cells will be harvested using the versene scraping method that I used during regular 
maintenance and passaging, then resuspended in lOOpl P3 Primary Cell 4D-Nucleofector X 
Solution (Lonza # V4XP-3024) with 5pg each of pZT-C13-Rl and pZT-C13-Ll (addgene) and 
10pg insertion plasmid. The cells with then be transfected by putting the mix into a 4D- 
Nucleofector X Unit (Lonza #AAF-1001X) and running the preset program CB-150. The cells 
are then re-plated onto 3 wells of a 6 well tissue culture plate in E8 media supplemented with 
Rock Inhibitor [6],
Colony Selection of Successfully Transfected Cells
To select for the cells with proper insertion, the transfected cells (2-3 days post 
transfection) were treated with the antibiotic G418(InvivoGen) for presence of an active 
neomycin gene. A kill curve analysis was performed on the undifferentiated B cells by plating 
them at different confluencies and exposing them to E8 growth media supplemented with G418 
at different concentrations (5pg/ml, lOpg/ml, 25pg/ml, 35pg/ml and 50pg/ml). Additional 
confirmation of successful transfection through gene expression analysis and sequencing can be 
performed.
Cell Biology Methods; Maintenance and Differentiation of the iPS cells
Two different lines of WTCII human induced pluripotent stem cells were tested; one 
older acquired before I joined the lab and one newer, received 2/2016 (henceforth called A and B 
respectively). Both were acquired from the Coriel Institute and reprogrammed from fibroblast 
cells using episomal vectors [16], The thawing, growth, and passaging methods used were all 
supplied by the Coriel Institute where our cells were acquired. The cells were grown on Matrigel
(Corning cat# 5187009) seeded plates incubated for 30 minutes at 37°C immediately before 
plating cells. Cells were fed with Essential 8 Medium (Life Technologies #A1517001) daily and 
split at 70-85% confluency. The A cells were passaged using StemPro Accutase (ThermoFisher 
A1110501) to single cell suspensions while the B cells were split using Versene (ThermoFisher 
15040066) and a scrapping method maintaining the cells as clumps. Cells were plated and 
allowed to grow for the first day after splitting in E8 media supplemented with ROCK inhibitor 
(Stemcell tech 72302).
Three differentiation methods were attempted as well—a monolayer method acquired 
from the Conklin lab, an embroid body differentiation method modeled after the one used by 
Burridge et al., and another monolayer one modeled after methods used by Van berg et al [5, 33], 
The Conklin protocol was received through a correspondence with Po-Lin So, PhD, who works 
in the lab of Bruce Conklin, MD, at the Gladstone Institutes. I performed the protocol as follows; 
Cells were plated at different concentrations at Day -2 and on Day 0 were fed with RPMI/B27 
medium (Life Technologies) without insulin supplemented with 12pM CHIR (Tocris #4953). 
Exactly 24 hours after this treatment, the media was changed to just RPMI/B27 without insulin. 
On Day 3 the cells were again fed with RPMI/B27 but supplemented with 5pM IWP2 (Tocris 
#3533). On Day 5 the cells were split using a 1:1 ratio and resuspended with RPMF27 without 
insulin supplemented with ROCK Inhibitor(Ri). On Day 6 the cells were fed again with 
RPMI/B27 to remove the Ri, and the medium was replaced every other day until Day 10 when 
the cells were fed with RPMI/B27 with insulin (Life Technologies #A14666SA). Media should 
be changed every three to four days and beating will be observed after Day 15.
For further analysis, the two lines were tested for expression of different pluripotency and 
cardiac makers through RNA analysis. The cells were first removed from their plate using the
respective splitting methods, then spun down and flash frozen with liquid nitrogen and stored at 
-80°C. The RNA of these cells were then isolated using a RNEasy Mini Kit according to the 
manufacturer’s specifications. The concentration of RNA was determined using a nanodrop 
machine, then lpg of RNA was converted to cDNA using a high capacity RNA to cDNA kit 
(Applied Biosystems 4387406). PCR testing on this cDNA was performed with primers for 
aMHC, NANOG, and OCT4 to test for expression within the cells. Specific primer sequences 
are outlined in table l(Eurofins).
Fluorescent Analysis of Beating Cells
Though I was unable to analyze successfully differentiated and beating transgenic 
cardiomyocytes, in the coming months, upon successful gene insertion and differentiation, the 
cells will be recorded beating and glowing green with the calcium expression associated with 
beating.
Results and Discussion
Creation of Insertion Plasmid
The digest of the CAG plasmid was rife with error and utterly unsuccessful throughout 
the majority of my research. After starting again from square 1—the agar stab received from 
addgene—I achieved more positive results and eventually got to step 3c in the plasmid construct. 
I will outline my research and thought process through my negative followed by my more 
promising.
Upon initial digest two bands were observed suggesting incomplete digest (Figure 3a). In 
attempts to fix this issue, the volume of the digest was changed and additional minipreps were 
performed in case my initial prep was compromised. These results also showed incomplete 
digest and little difference between the undigested control and the digested samples (Figure 3b). 
Though the data is not included, this procedure was repeated multiple times with varying preps, 
digestion times, restriction enzyme concentrations, and DNA concentrations. Additionally, a new 
ASCI restriction enzyme was ordered in case the sample I was using had gone bad but all results 
were identical—no digest at the ASCI site. All samples prepared had a characteristic 7kb band 
and <12kb band. The 7kb band is hypothesized to be a supercoiled plasmid which will travel 
more quickly due to its small size, while The 12kb band is considered an open circle of plasmid 
DNA that will travel more slowly [38], I expected to see and isolate a clean ~11Kb linear 
fragment but this wasn’t observed in any of my digests. The top line on the gel in figure 2b is an 
unknown very long fragment that may be contamination. Through further investigation of the 
ASCI, I found that this enzyme is blocked by CpG Methylation, and methylation of DNA can 
result in unsuccessful digests [18], Despite this potential confounding factor, I found that CpG 
methylation is mainly a concern in eukaryotic DNA and isn’t retained when the DNA is 
transferred to a bacterial host [2], Since the cells were acquired in DH5a bacterial cells, there is 
no CpG methylation present.
Due to the repeated failure of the ASCI digest, I performed multiple other digests using 
EcoRI, Sail, and Xhol (Figure 4). The Sail digest was unsuccessful, showing bands identical to 
the undigested plasmid and the ASCI while the EcoRI and Xhol digests showed linear 
fragments. Despite the EcoRI having 2 restriction sites on the plasmid, there is only one strong 
linear band suggesting digestion at only one site. On the other hand, Xhol digest was successful
and reveals that the plasmid has the potential to be digested. With this data I concluded that there 
is something wrong with the bases around the ASCI site (-5400 bp figure 1) due to the 
unsuccessful digest of Sail and the partial digest of EcoRI, both of which are within 50bps of the 
ASCI site (genotype and restriction enzyme locations acquired from addgene supplied data). 
Assuming either deletion or some other base pair alteration of this site, plasmid 1 and 2 from 
figure 3 were sequenced (figure 5). Despite the unsuccessful digests of ASCI and EcoRI, both 
sites were clearly observed in the sequence. The Sail site is present on plasmid 2 but on plasmid 
1 slight modifications were observed confirming my gel data. This data concluded my suspicion 
that there are slight modifications to this segment of DNA that may be negatively affecting my 
digests but the true reason for the digest failures remains largely unknown.
Three of my superiors have examined the results as well, performing their own separate 
minipreps and digests yet the results remain consistent. These perplexing and contradictory 
results have thrown a wrench in my plasmid protocol and effectively halted my whole project. A 
potential way to circumvent this issue is to find another digestion site within the 4000-5500 
region in attempts to excise the CAG GFP site while maintaining the neomycin gene to allow for 
antibiotic selection post transfection. Upon genomic analysis of the plasmid (though I am unsure 
I can still trust the addgene reference), I have been unsuccessful in finding such a site. An 
additional option is to create a blunt end at the Xhol site excising the neomycin gene (Figure la, 
Xhol at 3014). This has been proven successful through gel analysis though we would be unable 
to select the cells immediately post transfection. The only way to select for proper transfection 
would be to grow the cells in small wells from single colonies, genotype the colonies after 
growth and select the cells with the aMHC GCaMP8 insert. This process would be tedious and 
extremely inefficient as iPS cells have trouble growing as single cells. Due to time and financial
constraints I was unable to order an analyze a new CAG stock and I will continue to analyze this 
plasmid with the molecular biologists in this lab in attempts to elucidate the mechanism of my 
failure. If necessary, I will contact the manufacturer and Cerbini for further consultation.
After fishing the original bacterial stab of the CAG plasmid out of the freezer, I was able 
to retry this procedure starting completely over. This new trial was met with much more success 
and clear linear bands after CAG digest. After isolation the EcoRI digest was also successful 
showing presence of expected 8414bp fragment. The lack of success above can be attributed to 
contamination of my glycerol CAG stock or of my initial minipreps because there was 
unsuccessful ASCI digests from the very beginning.
Despite the errors in the CAG digest, the isolation of the aMHC-CaMP8 insert (figure 2a) 
was fairly successful. Upon initial digest, similar failures were observed with undigested plasmid 
present in my first Hindlll digest. Upon using a larger volume with more DNA and removing an 
unnecessary heat inactivation step, a clear linear fragment was observed post Hindlll digest 
(Figure 6). The band is widened and seemingly long potentially due to overloading the gel and 
after gel isolation a much cleaner band was observed. Like the digests, initial ligation attempts 
were met with failure but after tweaking the amounts of linker and total volume, successful 
ligation was achieved with bacterial growth on ampicillin plates (Figure 7b). The plates show 
growth of satellite colonies as well which is common for ampicillin. My control plate showed no 
bacterial growth confirming that there was no self-ligation of the digested plasmid, and that the 
Hindlll digest and gel isolation was successful (Figure 7a). Additionally, a dephosphorylation 
step was performed in step 2a in attempts to minimize self-ligation and this was proven 
successful by the lack of growth on the control plate [32], Ten colonies were picked, being 
careful not to pick satellites, and six were found to be strong positives through a Mfel digest
confirming that the Mfel linker has replaced the Hindm site (Figure 8a). Further confirmation of 
Mfel presence was confirmed in all six positive colonies through sequencing analysis (Figure 
8b). Notl digestion was also successful showing 2 clear bands after digest (Figure 9a). The 3kb 
band is expected while the longer band is expected to be ~7kb. Mfel digest of the longer band 
could not be confirmed as the band was extremely faint and there was no observable 700bp 
fragment (Figure 9b). This could be due to the fact that the band was run in an extremely wide 
lane distributing the DNA and potentially the 700bp band was too faint to be seen. Mfel digest 
was assumed to be successful due to previous data proving its presence and ability to be digested 
and isolation of the top band was successful though a very small amount of final insert was 
present (Figure 9c). Further testing, particularly of steps 2j-l, will be performed to examine the 
slight inconsistencies in data and the presence of a longer than expected final product. Also for 
successful insertion and ligation, there must be a large amount of insert fragment present so more 
DNA will have to be isolated than the tiny amount seen in figure 9c.
The ligation of the two plasmid fragments was performed and the product was 
transformed in DH5a bacteria plated on kanomycin. After allowing incubation, I saw the 
presence of three colonies on my many plates. This was a very low ligation success rate and is 
potentially due to the extremely low concentration of fragment vector and insert, about .0014 
pmol/pL of each. This is much lower than the concentrations recommended by the manufacturer, 
but nonetheless there was growth suggesting a circular plasmid with kanamycin present in the 
colonies. The reason for this growth can be attributed to three things; either successful ligation 
and plasmid transformation, self-ligation of CAG fragment and insertion, or possible 
contamination. To confirm that there was proper insertion I performed an EcoRI digest where the 
TALEN aMHC-GCaMP8 plasmid would linearize due to the presence of an EcoRI site on the
insert and a ligated CAG fragment or contamination would remain circular. This diagnostic test 
was inconclusive and due to time constraints I was unable to perform another. To continue my 
work one should perform more digests and potentially sequence to verify proper plasmid 
creation. If my plasmid isn’t present in this bacteria, I would suggest performing my procedure 
again but this time with much more DNA and elute into lower volumes causing higher 
concentrations to avoid the potential difficulties associated with ligating at such a low 
concentration of fragment DNA.
The utilization of a blunt and sticky end ligation was outlined because it is efficient and 
causes proper orientation of the insertion fragment. My sticky ends, despite being different 
digests, are expected to join because EcoRI and Mfel have complementary overhangs (AATT). 
The blunt end reactions didn’t require dNTPs in addition to the Klenow despite having 5’ 
overhangs because they were performed directly after digests where the digestion buffer would 
supply the needed material.
Differentiation of iPSCs to Cardiomvocvtes
The differentiation of the B cells was successful using the Conklin differentiation 
protocol. This was confirmed through observation of beating after day 15 and expression of 
aMHC (Figure 10 and 11a). The largest number of beating cells were observed from cells plated 
at 2.5E4 and 5E4 cells per well at day -2. The differentiation of the A cells was unsuccessful 
when subject to the Conklin, Burridge, and Van Berg protocols. Though there is expression of 
aMHC in these cells, there was never observed beating suggesting incomplete differentiation 
(Figure 1 lb). NANOG expression was seen in both populations of differentiated cells (Figure 
11). This can be attributed to presence of not completely undifferentiated colonies suggesting 
that the protocol is not completely efficient. Despite this expectation, there is no Oct4 RNA in
the differentiated cell lines though implying that NANOG expression is turned off later in the 
differentiation process. Research confirms this data and while Oct4 plays a large role in 
maintaining pluripotency, NANOG is considered to only inhibit ectoderm formation and not 
affect other lineages [35], Both cell lines were confirmed to be initially pluripotent before testing 
through presence of Oct4 and NANOG RNA (figure 11). In comparing RNA expression between 
differentiated cell lines, there is much higher expression of aMHC in B and more NANOG 
expression in A. This reinforces my conclusion that the B cells were differentiated much more 
efficiently.
The only true differences between the cells was method of passaging and passage number 
where the A cells were older by 5 passages. This suggests that passaging iPSCs with accutase 
into single colonies can affect the differentiation potential of the cells and that with more 
passages the cells lose differentiation potential as well. To avoid unwanted results, the RNA 
expression analysis utilizes primers on either side of long stretching introns such that DNA from 
the cells that may have been mistakenly isolated will not be replicated during the PCR step. This 
ensures only cDNA replication and that data is acquired only from RNA present in the cells.
Kill Curve Analysis
Though colony selection was unable to be performed, my kill curve analysis showed that 
that with a higher confluency, a longer amount of time and a higher concentration of antibiotics 
are needed to effectively kill cells. With a 20-40% initial plating confluence, three days at 
lOug/ml are required to effectively kill cells after 4 days, while at 15% confluency 5ug/ml is 
required to kill cells after 2 days. In the future I will repeat this analysis at 15% confluency with 
lower concentrations of G418 because 2 days is an extremely quick death and this concentration 
may kill my transfected cells if they are lightly expressing neomycin. Additionally, I would’ve
preferred to have numerical data to quantify the cells present rather than just observational 
analysis.
With current research in tissue engineering progressing, researchers require tools to 
confirm not only the creation of proper cells and tissues but also the functionality of these 
tissues. The cells I intended to create do both of these things and effectively adds an additional 
quantifiable measurement of successful differentiation, association, and beating of 
cardiomyocytes. While I was unable to complete this task due to failures in the molecular 
biology component and time constrants, I am poised to transfect and differentiate upon 
confirmation of plasmid creation. With the protocols and data I have presented, one could 
continue my work and effectively create a line of aMHC-GCaMP8 iPS cells. Though there has 
been research transfecting iPS cells with monitors for calcium expression, there is nothing 
currently (as of April 2016) like the cells I have intended to make and my research is unique in 
my usage of aMHC-GCaMP8, and TALEN transfection [1, 28], This research would not only 
provide innovation in heart research tools but also in human iPS cell editing. With more positive 
results showing viable methods of human iPSC editing, clinical trials are more likely to be 
approved further progressing the field of medicine. Additionally, the logic and research I have 
used can be applied to other calcium promoting cells and theoretically I could create multiple 
insertion fragments with varying promoters specific to different cell lines. A library of iPSCs 
transfected with different promoters for calcium expression coupled to GCaMP8 could provide 
limitless research potential particularly in studies of heart, muscle, or nerve cells. With the 
completion of this project, these tools can become a reality and human iPSC research can be
revolutionized.
This project has taught me how to research, create, and implement new technologies and 
ideas both alone and as part of a larger collective. Most importantly I have learned the true 
fluidity of biological research. My project and protocols involved dozens of changes, slowly 
chipping away and sculpting until results are finally beheld. Though I was unable to marvel at 
success, I can still see the art in the marble and know that my work is far from finished.
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Figure 1: CAG Plasmid Images. Both 
images show maps of the same 
plasmid while the top map (A) shows 
restriction sites with important ones 
used highlighted. Though EcoRI sites 
aren't labeled, they are marked by the 
black lines. B) Depicts the genes 
present note the two TALEN 
homologous arms circled in black and 
the neomycin gene boxed in yellow. 
(both images acquired from addgene 
site)
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Figure 2: Map of insertion fragment and site of plasmid insertion into genome. A) Map of the aMHC- 
GCaMP8 insert where restriction sites of interest are highlighted. Though excised genes aren't shown, 
there is an active ampicillin gene (image acquired from Bo Shui). B) Image of the site of plasmid insertion 
where the TALEN arms are bold and the site of DNA cutting is marked by lightning (figure ID from [1]).
Figure 3: ASCI Digests. A) First ASCI Digest with two bands suggesting incomplete digestion. 
B) The same digest run with different minipreps and an undigested control.
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Figure 4: CAG Plasmid Test Using 
3 Different Preps. Note that all the 
digestions in our area o f interest 
were unsuccessful, though there 
might be slight EcoRI as observed 
by the faint band m the top gel.
Undigested ASCI Sail Ccofti Undigested ASO Sail Ecofti
Plasmid 1 Plasmid 2
Figure 5: Sequencing data from iCAG plasmid 1 and 2. These are the same plasmids used in 
figure 3. The restriction sites are marked by a rectangular box with Sail being orange, EcoRI red, 
and ASCI blue. Based findings on peak readings more so than given sequences.
Figure 6: Initial GCaMP8 Plasmid Digest
Figure 7: Bacterial growth on Ampicillin plates after Mfel ligation. A) negative control with no 
Mfel added B) treatment with Mfel. Many satellite colonies observed around growth as image 
was taken a week after plating.
Figure 8: Confirmation of successful replacement of Hindlll site with Mfel. A) Depicts Mfel 
digest of 10 picked colonies with samples 1, 2, 3, 4, 8, and 10 being positive. C is an undigested 
GCaMP8 plasmid control. B) Sequencing data confirming the presence of an Mfel site in sample 
1. Mfel CAATTG in red box. Similar date was observed in all positive samples.
Figure 9: Isolation of alpha MHC GCaMPS insert. A) Gel post Notl digest where the top band 
was isolated. B) Gel post Mfel digest where again the top band was isolated. C) 5ul from gel 
isolation of long band in b to test for concentration.
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Figure 10: Screenshots from video of differentiated and functionally beating cardiomyoctes. A) 
Depicts the cells at their resting state. B) Shows contraction of the cardiac cells. Note the change 
particularly in the middle and on the right end of the cells. Images taken under 20X 
magnification.
Figure 11: Analysis of RNA expression in cultured cells. A) represents B cells with the 3rd 
lane marked D and the 4th and 5th marked P while B) represents analysis of the older A cells 
with the 4th lane marked D and the 5th lane marked P. The D lane is derived from cells that 
have been subject to a differentiation protocol while the P lanes are harvested pluripotent 
cells. The cells were tested for expression of Oct4, NANOG, and Alpha MHC. Note the 
differences in alpha MHC and NANOG expression.
NANOG AJpha MHC
Alpha MHC NANOG Oct4
Forward
Sequence
CGGCCCAGATTCTT
CAGGATT
GACTGAGCTGGTTGC
CTCAT
GTAGTCCCTTCGC
AAGCCCT
Reverse
Sequence
TCCCGTGATGAGGA
TGGACT
AGGGCCTTCTGCGTC
ACAC
ACCTTCCC AAAT A 
GAACCCCCA
Table 1: 5’ to 3’ sequences of primers used for RNA analysis
Figure 12: Successful CAG results: a) Shows post ASCI digest with the ~1 lkb linear band 
shown. For better understanding compare to unsuccessfull digests in figure 3 and 4. b) shows 
post EcoRI digest where the longer 8,414bp band is the vector plasmid, note the two bands 
confirming successful digest.
Figure 13: Bacterial Growth on Kanomvcin Plates Post Ligation: Shows the three bacterial 
colonies on the two plates suggesting the presence of a kan gene on a circular ligated plasmid. 
The colonies are circled in red. Low incidence of growth can be attributed to low fragment 
concentrations in the ligation.
Kanomycin
Neomycin
Figure 14: Diagram of insertion plasmid: Note that the image is not to scale. Also the black 
dashes mark the site where the ligation occurred.
Table 2: Kill Curve analysis. Three different kill curves were performed but it appears that with a 
higher confluency, a longer amount of time and a higher concentration of antibiotics are needed 
to effectively kill cells. With a 20-40% initial plating confluence, three days at lOug/ml are 
required to effectively kill cells, while at 15% confluency 5ug/ml is required to kill cells after 2 
days. Different trials separated by black row.
G418
concentration
Control 5ug/ml lOug/ml 25ug/ml 35ug/ml 50ug/ml
Day 0 All plates 
have some 
cell death but 
show 
consistent 
levels of 
growth and
are around 
15%
confluency
Day 1 Some floating 
cells observed 
but mainly 
good growth
Large
number of 
dead, floating 
cells
observed - 
still ~10% 
confluent 
with viable 
cells
Similar to 
5ug... but 
instead with 
~5%
confluency
Majority of 
cells dead >5% 
confluent
Tons of death 
(maybe plated 
at higher 
concentration, 
~5-10% 
confluency)
All cells 
floating/ 
dead, no 
pure iPS 
colonies 
remain
Day 2 Floating cells 
again
observed but 
definite cell 
growth is 
taking place, ~ 
20-30% 
confluent
No
observable
cellular
growth
Day 0 All cells 
appear to be 
in large well 
defined 
colonies with 
well at ~20- 
40%
confluency
Day 1 Floating dead 
cells observed 
with many 
embryonic 
colonies. 
Many have 
'skirt' and 
appear to be 
growing 
upwards but 
still viable and 
well defined 
cells.
Many
floating cells 
and
seemingly 
dying 
colonies, 
though there 
are still some 
well defined 
colonies.
Many
dead/dying 
cel Is—
characteristic 
defined 
edges appear 
lost
Almost 
complete 
death- very 
few viable 
colonies still 
growing
Extreme cell 
death, most 
cells appear as 
smudged 
cluster that 
doesn't 
appear to be 
growing
Day 2 Many cells 
appear to be 
dying
Most cells 
are
dissociating-
Living cells 
observed but 
not well
Most cells 
appear to be 
dead or dying.
(smudged) 
but there are 
still viable 
cells on the 
outsides of 
the plate
but a few 
viable
colonies still 
remain on 
the top.
defined in 
the
characteristic 
iPS nature.
No growth 
observed
Day 3 Still plenty of 
living cells, 
skirt appears 
to be growing 
g and some of 
the larger 
colonies 
appear to be 
growing up 
suggesting 
slight
differentiation
Floating cells 
suggest 
death but still 
colonies 
present >10%
No more 
death 
observed, 
but cells 
present 
appear non 
iPS and not 
growing
No additional 
floating cells 
but cells still 
plated appear 
to be
dead/dying
-more death 
observed
Day 4 Lot of cell 
death with 
floating cells 
but seemingly 
viable iPS 
colonies 
remain
No cell 
growth/ no 
living cells
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